Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.As of 9 Jun 2026, Medico Remedies share price is ₹42.26. The stock opened at ₹43.98, compared to its previous close of ₹43.67. During today's trading session, Medico Remedies share price moved in the range of ₹41.74 to ₹43.98, with an average price of ₹42.86 for the day. Looking at its last 52-week, the stock has touched a low of ₹41.74 and a high of ₹43.98. On the performance front, Medico Remedies share price has declined by 16.44% over the last six months and is down 11.08% on a year-on-year basis.
The market capitalization of Medico Remedies is ₹382 Crs, with a P/E ratio of 29.1 and a dividend yield of 0.00%.